연구소소개
핵심기술
신사업
NETWORK
2023
EGT022, an RGD-containing recombinant disintegrin, inhibits the VEGF-induced angiogenic process by targeting integrin β3 in endothelial cells
A Nonrandomized Phase 2 Trial of EG-Mirotin, a Novel, First-in-Class, Subcutaneously Deliverable Peptide Drug for Nonproliferative Diabetic Retinopathy
2022
1.A Nonrandomized Phase 2 Trial of EG-Mirotin, a Novel, First-in-class, Subcutaneously Delivered Peptide Drug for Non-Proliferative Diabetic Retinopathy. medRxiv 2022, 2021-12.
2021
The Effect of a TLR4 Agonist/Cationic Liposome Adjuvant on Varicella‐Zoster Virus Glycoprotein E Vaccine Efficacy: Antigen Presentation, Uptake and Delivery to Lymph Nodes
Culture media optimization for Chinese hamster ovary cell growth and expression of recombinant varicella-zoster virus glycoprotein E
2020
Liquid Chromatography/Electrospray Ionization Tandem Mass ectrometry‐based Structural Analysis of Deacylated Lipooligosaccharides From Escherichia coli.
2019
Efficient induction of cell-mediated immunity to varicella-zoster virus glycoprotein E co-lyophilized with a cationic liposome-based adjuvant in mice.
2018
Potentiation of Th1-Type immune responses to Mycobacterium tuberculosis antigens in mice by cationic liposomes combined with De-O-Acylated lipooligosaccharide.
2017
Increased immunogenicity and protective efficacy of a P. aeruginosa vaccine in mice using an Alum and De-O-Acylated lipooligosaccharide adjuvant system.
Effects of exogenous recombinant human bone morphogenic protein-7 on the corneal epithelial mesenchymal transition and fibrosis.